# RD3

## Overview
The RD3 gene encodes the RD3 protein, a crucial regulator of guanylate cyclase activity, particularly within the retina. This protein is integral to the phototransduction pathway, where it modulates the transport and function of guanylate cyclases GC1 and GC2, ensuring their proper localization and activity in photoreceptor cells. RD3's role is pivotal in maintaining the balance of cyclic GMP (cGMP) and calcium ions, which are essential for converting light into electrical signals in the retina. Structurally, RD3 is characterized by a monomeric four-helix bundle, facilitating its interaction with retinal guanylyl cyclase (RetGC) and inhibiting premature cGMP production. Mutations in the RD3 gene are linked to retinal dystrophies such as Leber congenital amaurosis type 12 (LCA12), underscoring its clinical significance in retinal health and disease (Molday2014Insights; Azadi2010RD3; Dizhoor2021Regulation).

## Structure
The RD3 protein, encoded by the RD3 gene, is characterized by a monomeric and elongated four-helix bundle structure. This structure is approximately 70 Å in length and 30 Å in width, consisting of four helices: α1 (P21-V51), α2 (P75-K87), α3 (P90-Q107), and α4 (V111-T139) (Peshenko2019Retinal; Ames2022Structural). The helices are arranged in an antiparallel fashion, with a hydrophobic core formed by residues such as L29, L33, F100, V114, F118, and L122, which stabilize the structure (Peshenko2019Retinal). The N-terminal and C-terminal ends of helices α1 and α4 are solvent-exposed and stabilized by salt bridges, contributing to the protein's rigidity (Ames2022Structural).

The RD3 protein has a highly negatively charged surface due to clustered glutamate residues, which may facilitate electrostatic interactions with its target, retinal guanylyl cyclase (RetGC) (Ames2022Structural). The protein's structure includes specific regions crucial for binding to RetGC, with certain mutations affecting its binding affinity (Peshenko2019Retinal). RD3 does not exhibit a quaternary structure involving dimerization, as it is confirmed to be a monomer (Peshenko2019Retinal). There is no information on post-translational modifications or splice variant isoforms in the provided context.

## Function
The RD3 gene encodes a protein that plays a critical role in the regulation of guanylate cyclase activity, particularly in photoreceptor cells. RD3 is essential for the proper functioning and survival of these cells by facilitating the transport of guanylate cyclases GC1 and GC2 from the endoplasmic reticulum to the photoreceptor outer segments. This transport is crucial for maintaining the balance of cyclic GMP (cGMP) and calcium ions, which are necessary for phototransduction, the process by which light is converted into electrical signals in the retina (Molday2014Insights; Aravindan2017Retinal).

RD3 inhibits the catalytic activity of guanylate cyclases during their trafficking, preventing premature cGMP production that could be toxic to the cells. This inhibition ensures that guanylate cyclases are only active in the appropriate cellular compartments, thus protecting photoreceptors from degeneration (Molday2014Insights; Dizhoor2021Regulation). RD3 is also involved in increasing guanylate kinase activity, which is essential for the nucleotide cycle in photoreceptors, further highlighting its role in maintaining photoreceptor cell function (Wimberg2018Control). RD3's expression is predominantly in the retina, but it is also found in other tissues, including the brain, where it may regulate guanylate cyclase activities (Chen2022Retinal).

## Clinical Significance
Mutations in the RD3 gene are associated with several retinal dystrophies, most notably Leber congenital amaurosis type 12 (LCA12), a severe form of early-onset blindness. In humans, mutations such as a homozygous G→A transition at the donor splice site of exon 2 lead to a premature stop codon, resulting in a truncated and non-functional RD3 protein, which is linked to LCA12 (Molday2014Insights; Friedman2006Premature). These mutations disrupt the normal function of RD3 in regulating guanylate cyclase activity, leading to impaired cGMP synthesis and photoreceptor degeneration (Azadi2010RD3).

In addition to LCA12, RD3 mutations are implicated in rod-cone dysplasia type 2 (rcd2) in dogs, highlighting the gene's role across species (Molday2014Insights). The RD3 protein's interaction with guanylate cyclases GC1 and GC2 is crucial for photoreceptor cell survival, and its dysfunction can lead to the constitutive closure of cGMP-gated channels, reducing intracellular calcium levels necessary for photoreceptor viability (Azadi2010RD3).

RD3 mutations are rare but significant in the context of retinal diseases, with a noted prevalence in certain populations, such as those in Mediterranean countries, suggesting a possible founder effect (Perrault2013Union). Despite their rarity, these mutations provide critical insights into the molecular mechanisms underlying retinal degenerative diseases.

## Interactions
The RD3 protein interacts with guanylate cyclases GC1 and GC2, playing a crucial role in their trafficking and function within photoreceptor cells. RD3 binds to these cyclases, inhibiting their catalytic activity and facilitating their exit from the endoplasmic reticulum, which is essential for their proper localization to the photoreceptor outer segments (Molday2014Insights; Azadi2010RD3). RD3 has a higher affinity for RetGC than guanylate cyclase-activating proteins (GCAPs), effectively outcompeting them and inactivating the RetGC:GCAP complex entirely (Dizhoor2021Regulation).

RD3 also forms a complex with GC1 and GCAP1, which is critical for the proper trafficking of GC1 to the photoreceptor outer segment. This complex is trafficked together in the same cargo vesicles, and the absence of any one of these proteins disrupts the targeting of the others (Zulliger2015Impaired). RD3's interaction with GCAP1 has been confirmed through immunoprecipitation and direct binding assays, indicating a direct interaction that influences the localization and function of these proteins (Zulliger2015Impaired). RD3's role in these interactions is vital for maintaining photoreceptor health and preventing degeneration associated with conditions like Leber congenital amaurosis (Zulliger2015Impaired).


## References


[1. (Azadi2010RD3) Seifollah Azadi, Laurie L. Molday, and Robert S. Molday. Rd3, the protein associated with leber congenital amaurosis type 12, is required for guanylate cyclase trafficking in photoreceptor cells. Proceedings of the National Academy of Sciences, 107(49):21158–21163, November 2010. URL: http://dx.doi.org/10.1073/pnas.1010460107, doi:10.1073/pnas.1010460107. This article has 77 citations.](https://doi.org/10.1073/pnas.1010460107)

[2. (Aravindan2017Retinal) Sheeja Aravindan, Dinesh Babu Somasundaram, Kwok Ling Kam, Karthikeyan Subramanian, Zhongxin Yu, Terence S. Herman, Kar-Ming Fung, and Natarajan Aravindan. Retinal degeneration protein 3 (rd3) in normal human tissues: novel insights. Scientific Reports, October 2017. URL: http://dx.doi.org/10.1038/s41598-017-13337-9, doi:10.1038/s41598-017-13337-9. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-13337-9)

[3. (Ames2022Structural) James B. Ames. Structural basis of retinal membrane guanylate cyclase regulation by gcap1 and rd3. Frontiers in Molecular Neuroscience, September 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.988142, doi:10.3389/fnmol.2022.988142. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.988142)

[4. (Molday2014Insights) Laurie L. Molday, Thomas Jefferies, and Robert S. Molday. Insights into the role of rd3 in guanylate cyclase trafficking, photoreceptor degeneration, and leber congenital amaurosis. Frontiers in Molecular Neuroscience, May 2014. URL: http://dx.doi.org/10.3389/fnmol.2014.00044, doi:10.3389/fnmol.2014.00044. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2014.00044)

[5. (Friedman2006Premature) James S. Friedman, Bo Chang, Chitra Kannabiran, Christina Chakarova, Hardeep P. Singh, Subhadra Jalali, Norman L. Hawes, Kari Branham, Mohammad Othman, Elena Filippova, Debra A. Thompson, Andrew R. Webster, Sten Andréasson, Samuel G. Jacobson, Shomi S. Bhattacharya, John R. Heckenlively, and Anand Swaroop. Premature truncation of a novel protein, rd3, exhibiting subnuclear localization is associated with retinal degeneration. The American Journal of Human Genetics, 79(6):1059–1070, December 2006. URL: http://dx.doi.org/10.1086/510021, doi:10.1086/510021. This article has 83 citations.](https://doi.org/10.1086/510021)

[6. (Dizhoor2021Regulation) Alexander M. Dizhoor and Igor V. Peshenko. Regulation of retinal membrane guanylyl cyclase (retgc) by negative calcium feedback and rd3 protein. Pflügers Archiv - European Journal of Physiology, 473(9):1393–1410, February 2021. URL: http://dx.doi.org/10.1007/s00424-021-02523-4, doi:10.1007/s00424-021-02523-4. This article has 15 citations.](https://doi.org/10.1007/s00424-021-02523-4)

[7. (Peshenko2019Retinal) Igor V. Peshenko, Qinhong Yu, Sunghyuk Lim, Diana Cudia, Alexander M. Dizhoor, and James B. Ames. Retinal degeneration 3 (rd3) protein, a retinal guanylyl cyclase regulator, forms a monomeric and elongated four-helix bundle. Journal of Biological Chemistry, 294(7):2318–2328, February 2019. URL: http://dx.doi.org/10.1074/jbc.ra118.006106, doi:10.1074/jbc.ra118.006106. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra118.006106)

[8. (Perrault2013Union) Isabelle Perrault, Alejandro Estrada-Cuzcano, Irma Lopez, Susanne Kohl, Shiqiang Li, Francesco Testa, Renate Zekveld-Vroon, Xia Wang, Esther Pomares, Jean Andorf, Nisrine Aboussair, Sandro Banfi, Nathalie Delphin, Anneke I. den Hollander, Catherine Edelson, Ralph Florijn, Marc Jean-Pierre, Corinne Leowski, Andre Megarbane, Cristina Villanueva, Blanca Flores, Arnold Munnich, Huanan Ren, Ditta Zobor, Arthur Bergen, Rui Chen, Frans P. M. Cremers, Roser Gonzalez-Duarte, Robert K. Koenekoop, Francesca Simonelli, Edwin Stone, Bernd Wissinger, Qingjiong Zhang, Josseline Kaplan, and Jean-Michel Rozet. Union makes strength: a worldwide collaborative genetic and clinical study to provide a comprehensive survey of rd3 mutations and delineate the associated phenotype. PLoS ONE, 8(1):e51622, January 2013. URL: http://dx.doi.org/10.1371/journal.pone.0051622, doi:10.1371/journal.pone.0051622. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0051622)

[9. (Chen2022Retinal) Yaoyu Chen, Anja U. Bräuer, and Karl-Wilhelm Koch. Retinal degeneration protein 3 controls membrane guanylate cyclase activities in brain tissue. Frontiers in Molecular Neuroscience, December 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.1076430, doi:10.3389/fnmol.2022.1076430. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.1076430)

[10. (Zulliger2015Impaired) Rahel Zulliger, Muna I. Naash, Raju V.S. Rajala, Robert S. Molday, and Seifollah Azadi. Impaired association of retinal degeneration-3 with guanylate cyclase-1 and guanylate cyclase-activating protein-1 leads to leber congenital amaurosis-1. Journal of Biological Chemistry, 290(6):3488–3499, February 2015. URL: http://dx.doi.org/10.1074/jbc.m114.616656, doi:10.1074/jbc.m114.616656. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m114.616656)

[11. (Wimberg2018Control) Hanna Wimberg, Ulrike Janssen-Bienhold, and Karl-Wilhelm Koch. Control of the nucleotide cycle in photoreceptor cell extracts by retinal degeneration protein 3. Frontiers in Molecular Neuroscience, February 2018. URL: http://dx.doi.org/10.3389/fnmol.2018.00052, doi:10.3389/fnmol.2018.00052. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2018.00052)